Eyeing big therapeutic push, Ginkgo bags $290M to build a cell programming empire
Ginkgo Bioworks is on a roll. Days after publicizing a plan to nurture new startups via partnerships with accelerators Y Combinator and Petri, the Boston biotech says it has raised another $290 million for its cell programming platform to reach further and wider.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 62,400+ biopharma pros reading Endpoints daily — and it's free.